ViroGates
ViroGates develops biomarker technology based on suPAR (soluble urokinase Plasminogen Activator Receptor), a biomarker of chronic inflammation that predicts patient outcomes before symptoms appear. The company's suPARnostic product line includes TurbiLatex for high-throughput CE-IVD approved testing on existing automated lab systems, ELISA for batch processing as the gold standard in suPAR testing, and Quick Triage…
Funding snapshot
About
ViroGates develops biomarker technology based on suPAR (soluble urokinase Plasminogen Activator Receptor), a biomarker of chronic inflammation that predicts patient outcomes before symptoms appear. The company's suPARnostic product line includes TurbiLatex for high-throughput CE-IVD approved testing on existing automated lab systems, ELISA for batch processing as the gold standard in suPAR testing, and Quick Triage for rapid 20-minute results in emergency settings. Higher suPAR levels are linked to greater risk of cancer, diabetes, cardiovascular disease, and organ failure, while lower levels indicate good underlying health. Founded in 2001 and headquartered in Copenhagen, Denmark, the company has raised approximately $28.4M in Series B funding. ViroGates differentiates itself through suPAR's unique ability to measure chronic inflammatory burden associated with aging and biological age, serving clinical diagnostics for emergency departments and acute care, as well as longevity clinics for preventive health management.
Business model
Genomics > Genomics Research > Biomarker Discovery
Institutional investors
Backed by funds in our directory
Latest coverage
No articles yet.
Similar startups
Immuneel
Developer of T-cell therapies for the treatment of cancer. It is developing cell therapies by using genetic engineering that modifies healthy immune cells to target cancerous cells.
ImmunoACT
Developer of cell and gene therapies for cancer treatment. It offers a lead product NexCAR19 Talicabtagene autoleucel for B‑cell malignancies such as B‑lymphoma and B‑acute lymphoblastic leukaemia.
HaystackAnalytics
EmbeDL is a provider of an edge AI optimization and deployment platform that streamlines the path from deep learning model development to hardware-ready deployment on embedded systems.
4baseCare
Sitehop is a provider of hardware-enforced network encryption solutions that delivers ultra-low latency, quantum-ready encryption for data-in-motion in critical networks through its SAFE Series product line.